Searchable abstracts of presentations at key conferences in endocrinology

ea0074ncc27 | Highlighted Cases | SFENCC2021

Hyperandrogenism and breast cancer in a postmenopausal woman – treatment challenges

Lider Burciulescu Sofia Maria , Dumitrascu Anda , Vladoiu Suzana , Caragheorgheopol Anda , Gheorghiu Monica Livia

Introduction: New-onset hyperandrogenism is rare in postmenopausal women and is usually associated with causes such as ovarian hyperthecosis, androgen-secreting tumor or medication. Patients with hyperandrogenism and breast cancer need a special attention when choosing the treatment.Case history: A 46-year old woman diagnosed with hormone receptor-positive breast cancer at 37 years old, for which she underwent surgery, chemotherapy, radiotherapy and horm...

ea0081p44 | Calcium and Bone | ECE2022

Bone mineral density, trabecular bone score and vertebral fractures in acromegalic patients

Sorohan Madalina , Dobre Ramona , Baciu Ionela , Galoiu Simona , Dusceac Roxana , Niculescu Dan , Caragheorgheopol Andra , Iordachescu Carmen , Poiana Catalina

Background: Acromegaly is characterized by increased prevalence of fragility vertebral fractures. Nonetheless, there are no clear recommendations for prevention of acromegalic osteopathy. Both bone mineral density (BMD) and trabecular bone score (TBS) lack clear evidence as prognostic factors for vertebral fractures (VF).Material and Methods: We performed an observational study on 31 acromegalic patients recruited prospectively. They were tested for alka...

ea0081ep714 | Pituitary and Neuroendocrinology | ECE2022

Block and replacement therapy of a patient with Cushing’s disease and aggressive complications: a case report

Tănasie Denisa-Isabella , Simona Andreea Găloiu , Caragheorgheopol Andra , Corneci Cristina , Baloseanu Nicoleta , Poiana Catalina

Introduction: We describe a patient with Cushing’s disease caused by a pituitary macroadenoma treated by double transsphenoidal surgery, stereotactic radiosurgery and steroidogenesis inhibitors and also the challenging management of a patient with multiple comorbidities, including chronic leg ulcers, which are related to increased morbidity and health costs.Case report: In October 2019, a 67-year-old patient presented with intense headache, left tem...

ea0081ep882 | Reproductive and Developmental Endocrinology | ECE2022

Anti-müllerian hormone analysis as a predictor of the polycystic ovary syndrome diagnosis in romanian women

Baculescu Nicoleta , Leonte Laura , Radian Serban , Gheorghiu Monica , Caragheorgheopol Andra , Biban Bianca , Serban Cristina , Grigorescu Florin , Poiana Catalina

Background: Higher anti-Müllerian hormone (AMH) values are associated with polycystic ovary syndrome (PCOS) and AMH is proposed as a marker of PCOS, however, the optimal diagnostic threshold is not yet defined.Aim: To study the significant correlations of AMH in PCOS and the accuracy and threshold of AMH for the PCOS diagnosis in Romania.Subjects and methods: Serum AMH, TT, LH, FSH, fasting glucose and insulin (Ins), HOMA-IR a...

ea0049ep206 | Paediatric endocrinology | ECE2017

Congenital adrenal hyperplasia: impact of therapy on growth and sexual maturation – a 5-year retrospective study of a Tertiary Pediatric Endocrinology Center

Procopiuc Camelia , Vintila Madalina , Gherlan Iuliana , Cirla Amel , Brehar Andreea , Caragheorgheopol Andra , Popa Suzana Vladoiu Oana , Dumitrescu Cristina

Objective: To evaluate the comparative effects of different glucocorticoid treatments on growth and sexual maturation in patients with congenital adrenal hyperplasia.Patients and methods: We conducted a retrospective observational cohort study in 78 patients (60 girls, 18 boys) diagnosed with congenital adrenal hyperplasia (CAH), followed-up for a period of 5 years. The majority had 21-hydroxylase deficiency (75 patients), 2 had 11-β hydroxylase def...

ea0049ep1063 | Pituitary - Clinical | ECE2017

“Toxic” Goiter Reveals Cushing’s Disease

Musat Madalina , Hortopan Dan , Oprea Luciana , Duceac Andreea , Manda Dana , Caragheorgheopol Andra , Iordachescu Carmen , Tupea Claudiu , Ciubotaru Vasile

Case presentation: Mrs. S presented in an endocrine clinic for fatigue, weight loss, restlessness and goiter. She was obese with a BMI of 51 kg/mp, hypertensive and had a medium size, nontender goiter. Lab test revealed hyperglycaemia, suppressed TSH (<0.03mUI/L), on two separate occasions, mid-normal fT4 and T3. Thyroid ultrasound revealed multinodular goiter. A diagnosis of polynodular goiter with subclinical hyperthyroidism was made and patient was commenced on thiamazo...

ea0049ep1466 | Thyroid (non-cancer) | ECE2017

Association between preoperative serum MMP-9 and histopathological features of thyroid tumors

Dobrescu Ruxandra , Picu Catalina , Schipor Sorina , Padure Adriana , Parvu Liliana , Manda Dana , Ioachim Dumitru , Badiu Corin , Caragheorgheopol Andra

Introduction: Matrix metalloproteinase-9 (MMP-9) is a zinc dependent proteolytic enzyme used by cells for degradation of the extracellular matrix during invasion and migration. There are only a few reports regarding the role played by MMP-9 in papillary thyroid carcinoma (PTC).Aim: To evaluate the association between MMP-9 secretion, reflected by preoperative serum levels and the histopathological features of thyroid tumors.Materia...

ea0041gp21 | Adrenal (2) | ECE2016

Clinical characteristics and tumour size evolution in patients with bilateral adrenal tumours

Galoiu Simona , Pena Raluca , Trifanescu Raluca , Niculescu Dan Alexandru , Dumitrascu Anda , Caragheorgheopol Andra , Iordachescu Carmen , Poiana Catalina

10% of patients with adrenal tumours have bilateral lesion.Objective: To evaluate clinical, imagistic and hormonal characteristics of bilateral adrenal tumours.Design and mehods: Retrospective series of 150 consecutive patients (104F, 46M) with bilateral adrenal tumours with maximal diameter of at least 1 cm, evaluated from 2001 to 2015 in a tertiary endocrinology clinic with clinical, hormonal and imagistic methods.<p class="a...

ea0041gp232 | Thyroid Cancer (1) | ECE2016

Does serum Galectin-3 add value in thyroid cancer diagnosis?

Dobrescu Ruxandra , Schipor Sorina , Manda Dana , Picu Catalina , Giulea Cosmin , Niculescu Ana-Maria , Badiu Corin , Caragheorgheopol Andra

Background: The role of circulating Galectin-3 as a potential biomarker of malignancy in thyroid disease remains inconclusive. In a previous pilot study we reported a significant difference between serum Gal-3 levels in papillary thyroid carcinoma (PTC) patients and those with benign pathology, but no association with tumor aggressiveness.Aim: We measured serum Gal-3 levels in a larger series of patients submitted to thyroidectomy, in order to assess its...

ea0037gp.24.06 | Thyroid–genetics | ECE2015

Gene expression profiling in differentiated thyroid carcinoma

Schipor Sorina , Niculescu Ana-Maria , Manda Dana , Caragheorgheopol Andra , Oros Sabina , Vladoiu Susana , Popa Oana , Paun Diana , Badiu Corin

Thyroid carcinoma is the most common endocrine malignancy and represents ~1% of all types of human cancer.Objective: As the molecular pathogenesis of thyroid cancer still remains to be clarified, the goal of our study was to find new molecular markers that could improve the diagnostics, follow-up protocols, treatment outcome, prognosis and the quality of life of differentiated thyroid cancer patients.Subjects and methods: Matched t...